Group 1 - The company, Yaxing Chemical (600319), announced that its stock trading has experienced unusual fluctuations, but internal and external operating conditions remain stable [1] - The production and operational activities of the company are normal, with no significant changes in the business environment [1] - The expected operational timelines for the 45,000 tons/year high-end new materials (PVDC) project, 500 tons/year hexachlorocyclotriphosphazene, and 500 tons/year benzyl chloride project are consistent with previously disclosed information in regular reports, showing no major changes [1] Group 2 - The company's main industry continues to face adverse factors such as intensified competition, which aligns with the information disclosed in regular reports, indicating no significant changes [1]

Core Viewpoint - The A-share market experienced a strong opening in July, with significant movements in various sectors, particularly in the chip industry and innovative pharmaceuticals, while some high-performing stocks faced declines [1][2]. Group 1: Market Performance - The Shanghai Composite Index rose by 0.39%, and the Shenzhen Component Index increased by 0.11%, while the ChiNext Index fell by 0.24% at the close [2]. - A total trading volume of nearly 1.5 trillion yuan was recorded in the A-share market [1]. Group 2: Chip Industry - The entire chip industry chain showed strong performance, with multiple stocks hitting the daily limit [1]. Group 3: Innovative Pharmaceuticals - Innovative pharmaceutical stocks surged in the afternoon, with Frontline Bio reaching the daily limit and companies like Kexing Pharmaceutical and Yuekang Pharmaceutical rising over 15% [5][8]. - The National Healthcare Security Administration announced measures to support the high-quality development of innovative drugs, focusing on issues in drug research, access, and payment systems [8]. Group 4: Chemical Sector - The chemical sector rebounded, with Aystar Chemical experiencing a rapid increase, hitting the daily limit within 8 minutes [10]. - Aystar Chemical has seen significant net inflows of over 100 million yuan in the past two days, indicating strong market interest [10]. - The rise in chemical stocks is attributed to the recent decline in international oil prices, which typically benefits chemical companies by lowering costs [13].

Group 1 - The company held its 13th meeting of the 9th Board of Directors on June 27, 2025, with all 9 directors present, complying with relevant laws and regulations [1][2] - The Board approved a proposal for its subsidiary, Weifang Yaxing New Materials Co., Ltd., to apply for a project loan of 490 million yuan from a banking consortium, with a loan term of up to 5 years and an annual interest rate not exceeding 5% [1][2] - The loan will be secured by the land use rights, production equipment, and construction projects of the PVDC project, with the company providing a credit guarantee for the subsidiary [1][2] Group 2 - The proposal received unanimous approval with 9 votes in favor, representing 100% of the voting rights present at the meeting [2] - The proposal will be submitted for review at the upcoming shareholders' meeting scheduled for July 14, 2025 [2]

Meeting Details - The third extraordinary general meeting of shareholders will be held on July 14, 2025, at 14:00 [1][2] - The meeting will take place at Yaxing Building, No. 321, Beigong East Street, Kuiwen District, Weifang City, Shandong Province [1] - Voting will be conducted through both on-site and online methods using the Shanghai Stock Exchange's voting system [2][3] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system, either through the trading system or the internet voting platform [3][4] - Voting time for the online platform is from 9:15 to 15:00 on the day of the meeting [2] - Shareholders holding multiple accounts can vote through any of their accounts, and the total voting rights are based on the number of shares held across all accounts [3][4] Agenda Items - The meeting will review a proposal regarding a subsidiary's application for a project loan and the provision of guarantees [1][2] - The proposal will be disclosed in detail in a separate announcement on the same day [1] Attendance - Shareholders registered by the close of trading on the record date of July 7, 2025, are eligible to attend the meeting [4] - Other attendees include company directors, supervisors, senior management, and appointed lawyers [4] Proxy Voting - Shareholders can appoint a proxy to attend the meeting and vote on their behalf [4][5] - The proxy must be authorized through a written power of attorney, which specifies the voting intentions [5][6]

证券代码：600319 证券简称：亚星化学 公告编号：临 2025-029 潍坊亚星化学股份有限公司 关于子公司向银行申请项目贷款并为其提供担保的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | | | 被担保人名称 本次担保金额 | 49,000 | 潍坊亚星新材料有限公司 万元 | | | --- | --- | --- | --- | --- | --- | | 担 保 | 对 | | | | | | 象 | | 实际为其提供的担保余额 | 37,692.65 | 万元 | | | | | 是否在前期预计额度内 | □是 | 否 | □不适用：_________ | | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | 担保对象及基本情况 累计担保情况 二、被担保人基本情况 （一）基本情况 | | | | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 | 37,692.65 | | 子公司对外担保 ...

证券代码：600319 证券简称：亚星化学 公告编号：2025-030 潍坊亚星化学股份有限公司 关于召开2025年第三次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东大会类型和届次 2025年第三次临时股东大会 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 7 月 14 日 14 点 00 分 召开地点：山东省潍坊市奎文区北宫东街 321 号亚星大厦 股东大会召开日期：2025年7月14日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 7 月 14 日 至2025 年 7 月 14 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易 ...

股票代码：600319 股票简称：亚星化学 编号：临 2025-028 潍坊亚星化学股份有限公司 同意公司子公司潍坊亚星新材料有限公司（以下简称"亚星新材料"）向青 岛银行、日照银行和威海银行组成的银团申请 4.9 亿元项目贷款，借款期限为自 借款之日起不超过 5 年,票面利率年化不高于 5%（含），需抵押亚星新材料所有 的 PVDC 项目土地使用权、生产设备及在建工程，且公司为亚星新材料上述业务 提供信用担保。 详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《关于子公 司向银行申请项目贷款并为其提供担保的公告》（公告编号：临 2025-029） 表决结果：同意票 9 票，反对票 0 票，弃权票 0 票，同意票占出席会议表决 权的 100%。 该项议案尚需提交公司股东大会审议。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 潍坊亚星化学股份有限公司（以下简称"公司"）于 2025 年 6 月 24 日发出 关于召开第九届董事会第十三次会议的通知，于 2025 年 6 月 27 ...

Core Viewpoint - The company, Weifang Yaxing Chemical Co., Ltd., is set to hold an investor performance briefing for the fiscal year 2024 and the first quarter of 2025 on July 2, 2025, to enhance investor understanding of its operational results and financial status [1][2]. Group 1: Meeting Details - The performance briefing will take place on July 2, 2025, from 10:00 AM to 11:00 AM [1][2]. - The meeting will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [1][2]. - Investors can submit questions from June 25, 2025, to July 1, 2025, through the Roadshow Center website or via the company's email [3]. Group 2: Participants and Contact Information - Key participants in the meeting will include General Manager Lu Weidong, Board Secretary Li Wenqing, Chief Financial Officer Lun Xiuhua, and Independent Director Fu Xinggang [2]. - Investors can contact the company's securities department at phone number 0536-8591866 or via email at Roth163@163.com for inquiries [3]. Group 3: Post-Meeting Access - After the meeting, investors will be able to view the meeting's proceedings and key content on the Shanghai Stock Exchange Roadshow Center website [3].

证券代码：600319 证券简称：亚星化学 编号：临 2025-027 潍坊亚星化学股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 07 月 02 日（星期三）上午 10:00-11:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 06 月 25 日(星期三)至 2025 年 07 月 01 日(星期二)前登 录上证路演中心网站首页点击"提问预征集"栏目或通过潍坊亚星化学股份有限 公司（以下简称"公司"）邮箱（Roth163@163.com）进行提问。公司将在说明会 上在信息披露允许的范围内对投资者普遍关注的问题进行回答。 公司已于2025年4月26日发布了2024年年度报告和 2025年第一季度报告， 为便于广大投资者更全面深入 ...

Meeting Overview - The annual general meeting of shareholders was held on June 3, 2025, at the company's headquarters in Weifang, Shandong Province [1] - The meeting was attended by shareholders representing 47.3269% of the total shares [1] - The voting method combined on-site and online voting, complying with relevant laws and regulations [1] Voting Results - All non-cumulative voting proposals were approved with a high majority, with the following voting results: - Proposal 1: 181,298,241 votes in favor (98.8050%), 2,175,101 votes against (1.1853%), and 17,600 abstentions (0.0097%) [1] - Proposal 2: 181,298,841 votes in favor (98.8053%), 2,175,101 votes against (1.1853%), and 17,000 abstentions (0.0094%) [1] - Proposal 3: 181,297,841 votes in favor (98.8047%), 2,176,101 votes against (1.1859%), and 17,000 abstentions (0.0094%) [1] - Proposal 4: 181,298,141 votes in favor (98.8049%), 2,178,801 votes against (1.1874%), and 14,000 abstentions (0.0077%) [1] Legal Compliance - The meeting and voting procedures were confirmed to be in accordance with the Company Law, Securities Law, and the company's articles of association by the legal representatives [4]